Literature DB >> 7798119

Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu).

F Heidenreich1, R Schober, U Brinck, H P Hartung.   

Abstract

We report the clinical and autopsy studies of a patient with an unusual combination of multiple paraneoplastic neurological syndromes in association with antibodies to a 35-40 kDa neuronal nucleo-protein (anti-Hu). Neurological disease preceded the detection of a small cell carcinoma of the lung. The patient had combined sensory and motor neuronopathy or neuropathy, cerebellar degeneration, brain-stem and limbic encephalitis, and clinical evidence of the Lambert-Eaton myasthenic syndrome and gastrointestinal pseudo-obstruction of paraneoplastic origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798119     DOI: 10.1007/bf00919593

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients.

Authors:  J Dalmau; F Graus; M K Rosenblum; J B Posner
Journal:  Medicine (Baltimore)       Date:  1992-03       Impact factor: 1.889

2.  The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.

Authors:  C Leveque; T Hoshino; P David; Y Shoji-Kasai; K Leys; A Omori; B Lang; O el Far; K Sato; N Martin-Moutot
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

3.  Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes.

Authors:  H F Furneaux; L Reich; J B Posner
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

4.  "Limbic encephalitis" and its association with carcinoma.

Authors:  J A Corsellis; G J Goldberg; A R Norton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

5.  Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction.

Authors:  J S Chinn; M D Schuffler
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

6.  Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis.

Authors:  J Dalmau; H M Furneaux; R J Gralla; M G Kris; J B Posner
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

7.  [Paraneoplastic encephalomyelitis and Lambert-Eaton syndrome].

Authors:  A Pou Serradell; J Fueyo; C Gomez; C Oliveras; J M Espadaler; F Alameda; F Graus
Journal:  Rev Neurol (Paris)       Date:  1992       Impact factor: 2.607

8.  Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.

Authors:  K A Jaeckle; F Graus; A Houghton; C Cardon-Cardo; S L Nielsen; J B Posner
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

9.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

Authors:  J H O'Neill; N M Murray; J Newsom-Davis
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

10.  Limbic encephalopathy as a nonmetastatic complication of oat cell lung cancer. Its reversal after treatment of the primary lung lesion.

Authors:  L V Brennan; P R Craddock
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

View more
  3 in total

1.  Enteric Nervous System: Neuropathic Gastrointestinal Motility.

Authors:  Jackie D Wood
Journal:  Dig Dis Sci       Date:  2016-07       Impact factor: 3.199

Review 2.  Neuropathophysiology of functional gastrointestinal disorders.

Authors:  Jackie D Wood
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

Review 3.  Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review.

Authors:  Simone Rossi; Elena Merli; Roberto De Giorgio; Roberto D'Angelo; Rita Rinaldi; Gaia Deleonardi; Vincenzo Mastrangelo; Anna Simona Sasdelli; Alessandro Di Federico; Maria Guarino; Vincenzo Donadio; Loris Pironi; Francesco Gelsomino
Journal:  J Neurol       Date:  2021-05-02       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.